Goodrick v. Idaho Department of Corrections

CourtDistrict Court, D. Idaho
DecidedApril 22, 2020
Docket1:17-cv-00265
StatusUnknown

This text of Goodrick v. Idaho Department of Corrections (Goodrick v. Idaho Department of Corrections) is published on Counsel Stack Legal Research, covering District Court, D. Idaho primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Goodrick v. Idaho Department of Corrections, (D. Idaho 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF IDAHO

DAN GOODRICK,

Plaintiff, Case No. 1:17-CV-00265-BLW

vs. MEMORANDUM DECISION AND ORDER DEBBIE FIELD, DAVID McCLUSKY, CINDY WILSON, CORIZON, DR. APRIL DAWSON, DR. PHILLIP PETERSEN, DR. CLAYTON BUNT and JANE or JOHN DOES 1-X,

Defendants.

In the Successive Review Order addressing Plaintiff Dan Goodrick’s Amended Complaint, the Court notified Plaintiff that he could not proceed on his claims that he was not properly treated for his Hepatitis C condition if his claims (1) were or should have been asserted in an earlier Hepatitis C case he filed and litigated to a conclusion in Case No. 3:09-cv-00355-EJL, Goodrick v. Sandy, et al. (“Case 2009”), or (2) were barred by the statute of limitations. (Dkts. 17, 15.) The Court permitted Plaintiff to proceed to the

MEMORANDUM DECISION AND ORDER - 1 next stage of litigation, which is to face Defendants’ procedural defenses, whereupon the Court will determine whether Plaintiff can proceed to the merits of any of his claims. On December 4, 2019, Defendants filed a joint Motion for Summary Judgment,

asserting that Plaintiff’s claims were barred by res judicata and the statute of limitations, pursuant to the Successive Review Order (Dkt. 17), as well asserting that the claims are subject to dismissal for failure to exhaust administrative remedies, a defense the Court suggested could be pursued in the Initial Review Order. (Dkt. 11.) Plaintiff has filed his Response, and Defendants have filed their Reply. (Dkts. 54, 55.) The operative pleading

at issue is Plaintiff’s Amended Complaint. (Dkt. 15.) Having fully reviewed the record, the Court finds that the parties have adequately presented the facts and legal arguments in the briefs and record and that the decisional process would not be significantly aided by oral argument. Therefore, the Court shall decide this matter on the written motions, briefs and record without oral argument. D.

Idaho L. Civ. R. 7.1(d). Accordingly, the Court enters the following Order granting in part and denying in part the Motion for Summary Judgment. GENERAL BACKGROUND FACTS Plaintiff, a prisoner who has been incarcerated in the Idaho Department of Corrections (IDOC) prison system since 1992, was first diagnosed with Hepatitis C about

1994. Thereafter, he was seen in the prison’s chronic health care clinic every six months

MEMORANDUM DECISION AND ORDER - 2 for a blood draw to test ALT levels. The theory behind the testing was that higher ALT levels can indicate cirrhosis of the liver. He had a liver biopsy in 2009, due to his complaints to medical providers that he believed his health was deteriorating. The report

showed: Core biopsies of liver parenchyma contain mild portal chronic inflammation with no significant piecemeal necrosis. There is minimal steatosis presented (approximately 5%, microvesticular). Lobules show focal chronic inflammation. Trichrome stains demonstrate fibrous portal expansion. Reticulin stain shows a relatively intact reticulin network. PAS stain shows introacytoplasmic glycogen PAS with diastase shows no diagnostic intercytoplasmic inclusions. Iron statins show focal iron deposition. There are no features of malignancy.

(Dkt. 50-5, p. 5.) When Dr. Bunt and Dr. Dawson, medical doctors who worked for Correctional Medical Services (CMS) (the contracted medical provider for the prison, now called Corizon), reviewed his 2009 liver biopsy, they decided that anti-viral treatment Interferon (the standard treatment during that time period) was not warranted based on their company standards, and instead recommended continued monitoring and a follow-up liver biopsy. (See Amended Complaint, Dkt. 15, pp. 8-9.) Plaintiff alleges that, in 2009, Dr. Bunt recommended that Plaintiff have continued regular monitoring, as well as a follow-up liver biopsy in two years and in five years. (Dkt. 54-1, pp. 9-10.) Plaintiff’s

MEMORANDUM DECISION AND ORDER - 3 medical records show that, at the least, a follow-up biopsy was to be performed five years from 2009 – in 2014. (Dkt. 50-5, pp. 13-16.) Plaintiff disagreed with the prison doctors’ decision denying him Interferon

treatment. He filed the lawsuit in Case 2009. After discovery and briefing, United States District Judge Edward J. Lodge granted summary judgment for the defendants, concluding that they had not been deliberately indifferent to Plaintiff’s serious medical needs. Plaintiff filed an appeal. The United States Court of Appeals for the Ninth Circuit affirmed denial of Plaintiff’s claims. (See Docket in Case 2009.)

On April 8, 2014, Plaintiff, who was then 64 years old, had a chronic disease follow-up visit with Physician’s Assistant (PA) Matthew Valley, according to medical records submitted by Defendants. Plaintiff’s APRI score was 2.98.1 The notes say that Plaintiff did not want a liver biopsy but would agree to an ultrasound. (Id., p. 20.) Plaintiff disputes that declined a biopsy.

1 APRI is an acronym for “AST to Platelet Ratio Index.” (APRI). For explanatory purposes only (and not for the truth of the matter), the Court notes that a group of experts opined: “In a meta-analysis of 40 studies, investigators concluded that an APRI score greater than 1.0 had a sensitivity of 76% and specificity of 72% for predicting cirrhosis. In addition, they concluded that APRI score greater than 0.7 had a sensitivity of 77% and specificity of 72% for predicting significant hepatic fibrosis.” Another set of experts opined: “For detection of cirrhosis, using an APRI cutoff score of 2.0 was more specific (91%) but less sensitive (46%).” See https://www.hepatitisc.uw.edu/page/clinical-calculators/apri (citing Lin ZH, Xin YN, Dong QJ, et al., “Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.” Hepatology. 2011;53:726-36; and Chou R, Wasson N., “Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.” Ann Intern Med. 2013;158:807-20).

MEMORANDUM DECISION AND ORDER - 4 On February 6, 2015, Plaintiff had a bilateral renal ultrasound. (Dkt. 54-2, p. 20.) The “Indications” section of the report shows the test was done for “Hematuria, Proteinuria, and new onset chronic kidney disease.” Id. The findings were that the right

and left kidneys were normal. (Id.) On April 23, 2015, Plaintiff had an abdominal ultrasound. The history noted on the ultrasound report was “Hepatitis-C with probable cirrhosis; hepatocellular carcinoma screening.” (Dkt. 54-3, p. 2.) The conclusion was: “Solitary gallstone with probable low grade chronic cholecystitis.” (Id.)

In October 2015, Plaintiff was rushed to the IMSI medical unit with blood pressure of 230/190. (Dkt. 15, p. 12.) He asserts that he was given a drug to keep him sedated for three weeks, and then he was taken to the hospital because his “kidneys began to shut down.” (Id.) On October 29, 2015, Plaintiff presented to the St. Luke’s Nephrology Clinic for diagnosis and treatment for suspected chronic kidney disease. Dr.

Liang Wu’s report from October 29, 2015, contained an assessment that Plaintiff had chronic kidney disease, stage 3, with “progressive worsening within the past 12 months.” (Dkt. 50-5, p. 30.) Dr. Wu suggested a course of treatment to prison doctors—first, a regimen to improve Plaintiff’s kidney condition, and second, treatment with Harvoni medication, intended to eradicate Hepatitis C from his system after his kidney condition

had stabilized. (Id.)

MEMORANDUM DECISION AND ORDER - 5 An abdomen ultrasound report, from July 26, 2018, three years later, again shows normal kidneys. It also showed a “homogeneous liver” with “lobulated contours” that “may be a reflection of cirrhosis.” (Dkt. 50-5).)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McNutt v. General Motors Acceptance Corp.
298 U.S. 178 (Supreme Court, 1936)
Johnson v. Railway Express Agency, Inc.
421 U.S. 454 (Supreme Court, 1975)
Parklane Hosiery Co. v. Shore
439 U.S. 322 (Supreme Court, 1979)
Nevada v. United States
463 U.S. 110 (Supreme Court, 1983)
Wilson v. Garcia
471 U.S. 261 (Supreme Court, 1985)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Booth v. Churner
532 U.S. 731 (Supreme Court, 2001)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Richard Augustine v. United States
704 F.2d 1074 (Ninth Circuit, 1983)
Dale R. Kichline v. Consolidated Rail Corporation
800 F.2d 356 (Third Circuit, 1986)
Charles Leonard Elliott v. City of Union City
25 F.3d 800 (Ninth Circuit, 1994)
Murphy v. Schneider National, Inc.
362 F.3d 1133 (Ninth Circuit, 2004)
Madero Pouncil v. James Tilton
704 F.3d 568 (Ninth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Goodrick v. Idaho Department of Corrections, Counsel Stack Legal Research, https://law.counselstack.com/opinion/goodrick-v-idaho-department-of-corrections-idd-2020.